close

ev3 Inc. operates as an endovascular company that focuses on identifying and treating peripheral vascular disease, including lower extremity arterial disease and neurovascular disease. It develops, manufactures, and markets a range of products that include stents, atherectomy plaque excision products, thrombectomy and embolic protection devices, percutaneous transluminal angioplasty balloons, and other procedural support products for the peripheral vascular market. The company also offers embolic coils, liquid embolics, flow directed, and other micro catheters; occlusion balloon systems; guidewires; and neuro stents for the neurovascular market. It markets its products in the United States, Europe, and Canada through a direct sales force; and through distributors in other international markets. The company's customers include a section of physicians, including interventional radiologists, neuroradiologists, vascular surgeons, neuro surgeons, endovascular specialists, and interventional cardiologists. ev3 Inc. was founded in 2000 and is headquartered in Plymouth, Minnesota.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	22.56
Volume	(mio) 1.37
Volume Avg	(mio) 3.55
52 Week High	22.50
52 Week Low	9.71
PE	46.74
PE (group average)	39
EPS Year	0.48
EPS change Q/Q	100%
EPS change Q/Q Yr ago	-1000%
EPS change Q/Q next Q est	-14.29%
EPS change Y/Y	1000%
REV change Q/Q	12.41%
REV change Q/Q Yr ago	19.51%
EPS next Q est	0.14
EPS next Y est	0.68
Divident Annual	0.00
Dividend Yield	0%